Skip to main content
. 2008 Feb 16;12(6a):2416–2426. doi: 10.1111/j.1582-4934.2008.00283.x

Figure 2.

Figure 2

PED expression levels in NSCLC cancer samples. Immunohistochemical analysis of paraffin-embedded NSCLC sections labelled with anti-PED antibody (1:5000) and revealed by secondary, biotinylated antibody. (A) Negative; (B) mild; (C) moderate and (D) strong staining.